Home LiteratureArticle Details
PMID: 20593409 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Variations in stromal signatures in breast and colorectal cancer metastases.

The Journal of pathology ·Vol. 222 ·No. 2 ·2010-10-00 ·Pages 158-65

Webster JA, Beck AH, Sharma M, Espinosa I, Weigelt B, Schreuder M, Montgomery KD, Jensen KC, van de Rijn M, West R

Abstract

The tumour microenvironment (TME) plays an important role in tumour survival and growth, but little is known about the degree of preservation between different stromal response patterns found in primary tumours and their metastases. We have previously identified gene expression profiles for two distinct stromal signatures in breast carcinoma of fibroblast (aka DTF) and macrophage (aka CSF1) response and found them to be correlated with clinicopathological features, including outcome. In this study, we compare the DTF fibroblast and CSF1 macrophage stromal response patterns in primary breast and colorectal cancers to their matched lymph node metastases. In both breast and colorectal cancer, there was a significant positive correlation between the CSF1 macrophage signature in the primary tumours and the matched lymph node metastases, as assessed by immunohistochemical markers. No such correlation was observed for the DTF fibroblast signature. A similar result was seen in independent analysis of two published gene expression microarray datasets. The variations of these stromal reaction patterns from the primary to the metastasis shed light on the relationship between the neoplastic cells and the non-neoplastic cells in the TME. The preservation of the CSF1 macrophage response pattern in metastases lends support to targeting the CSF1 pathway in cancer.

MeSH Terms
Adenocarcinoma/metabolism,secondary Biomarkers, Tumor/metabolism Breast Neoplasms/genetics,metabolism,pathology Colorectal Neoplasms/genetics,metabolism,pathology Female Fibroblasts/metabolism Gene Expression Profiling/methods Gene Expression Regulation, Neoplastic Humans Lymphatic Metastasis/genetics,pathology,physiopathology Macrophage Colony-Stimulating Factor/genetics,metabolism Neoplasm Proteins/genetics,metabolism Oligonucleotide Array Sequence Analysis/methods Stromal Cells/metabolism
Chemicals
Biomarkers, Tumor Neoplasm Proteins Macrophage Colony-Stimulating Factor
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Webster Jonathan A
Department of Pathology, Stanford University Medical Center, Stanford, CA, USA.
Beck Andrew H
Sharma Mimansa
Espinosa Inigo
Weigelt Britta
Schreuder Marthe
Montgomery Kelli D
Jensen Kristin C
van de Rijn Matt
West Robert
References (24)
24 references, click to expand
  1. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival.
    Int J Oncol. 2000 Sep;17(3):445-51 PMID: 10938382
  2. Prognostic value of tumor-associated macrophage count in human bladder cancer.
    Int J Urol. 2000 Jul;7(7):263-9 PMID: 10910229
  3. No common denominator for breast cancer lymph node metastasis.
    Br J Cancer. 2005 Oct 17;93(8):924-32 PMID: 16189523
  4. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
    Am J Gastroenterol. 2004 Sep;99(9):1667-74 PMID: 15330899
  5. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients.
    Anticancer Res. 2003 Nov-Dec;23(6D):5015-22 PMID: 14981961
  6. The fibromatosis signature defines a robust stromal response in breast carcinoma.
    Lab Invest. 2008 Jun;88(6):591-601 PMID: 18414401
  7. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer.
    Anticancer Res. 2004 Sep-Oct;24(5C):3335-42 PMID: 15515429
  8. The macrophage colony-stimulating factor 1 response signature in breast carcinoma.
    Clin Cancer Res. 2009 Feb 1;15(3):778-87 PMID: 19188147
  9. Estimation of tumor heterogeneity using CGH array data.
    BMC Bioinformatics. 2009 Jan 09;10:12 PMID: 19134174
  10. Gene expression profiles of primary breast tumors maintained in distant metastases.
    Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15901-5 PMID: 14665696
  11. Friends or foes - bipolar effects of the tumour stroma in cancer.
    Nat Rev Cancer. 2004 Nov;4(11):839-49 PMID: 15516957
  12. Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis.
    Proteomics. 2008 Dec;8(23-24):5038-52 PMID: 19003862
  13. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.
    J Exp Med. 2001 Mar 19;193(6):727-40 PMID: 11257139
  14. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
    Cell. 2005 May 6;121(3):335-48 PMID: 15882617
  15. Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.
    Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):173-7 PMID: 14734466
  16. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
    Breast Cancer Res Treat. 2010 Sep;123(2):397-404 PMID: 19949854
  17. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth.
    PLoS One. 2009 Aug 10;4(8):e6562 PMID: 19668347
  18. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.
    Cancer Res. 1999 Oct 1;59(19):5002-11 PMID: 10519415
  19. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density.
    Oncol Rep. 2005 Aug;14(2):425-31 PMID: 16012726
  20. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.
    Clin Cancer Res. 2007 Mar 1;13(5):1472-9 PMID: 17332291
  21. Determination of stromal signatures in breast carcinoma.
    PLoS Biol. 2005 Jun;3(6):e187 PMID: 15869330
  22. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis.
    Cancer. 2004 Mar 15;100(6):1110-22 PMID: 15022276
  23. Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma.
    Anticancer Res. 2002 Nov-Dec;22(6C):4281-4 PMID: 12553070
  24. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).
    Blood. 2005 Sep 15;106(6):2169-74 PMID: 15933054
Article Info
Journal
The Journal of pathology
Abbr.
J Pathol
ISSN
1096-9896
Published
2010-10-00
Pages
158-65
Language
English
Region
England
NLM ID
0204634
PMCID
PMC2935495
Subset
IM
Grants
NCI NIH HHS · R01 CA129927 · United States
NCI NIH HHS · CA129927 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com